The genetic basis of primary aldosteronism.

Abstract:

:Primary aldosteronism is commonly regarded as largely sporadic, but both germline and somatic mutations are increasingly recognized as underlying the condition. Three germline mutations causing familial hyperaldosteronism have been described, dubbed FH I (due to a CYP11B1/CYP11B2 chimera), FH II (localized to chromosome 7p22, exact location of mutation[s] unknown to date), and FH III (reflecting a T158A mutation in the potassium channel subunit KCNJ5). Major contributions (FH I, FH III) have been by Lifton and his associates; more recently they have also described somatic mutations (G151R, L168R) in KCNJ5 in over a third of aldosterone-producing adenomas, with results confirmed, refined, and extended in a much larger study from Europe. These findings have sparked considerable interest, and over the next 12 months a number of additional reports can be confidently expected to throw light on both normal and abnormal adrenocortical zonation and the genesis of primary aldosteronism.

journal_name

Curr Hypertens Rep

authors

Funder JW

doi

10.1007/s11906-012-0255-x

subject

Has Abstract

pub_date

2012-04-01 00:00:00

pages

120-4

issue

2

eissn

1522-6417

issn

1534-3111

journal_volume

14

pub_type

杂志文章,评审
  • Relationship Between Antihypertensive Medications and Cognitive Impairment: Part I. Review of Human Studies and Clinical Trials.

    abstract:PURPOSE OF REVIEW:There is an established association between hypertension and increased risk of poor cognitive performance and dementia including Alzheimer's disease; however, associations between antihypertensive medications (AHMs) and dementia risk are less consistent. An increased interest in AHM has resulted in ex...

    journal_title:Current hypertension reports

    pub_type: 杂志文章,评审

    doi:10.1007/s11906-016-0674-1

    authors: Yasar S,Schuchman M,Peters J,Anstey KJ,Carlson MC,Peters R

    更新日期:2016-08-01 00:00:00

  • Integrative Physiological Aspects of Brain RAS in Hypertension.

    abstract:PURPOSE OF REVIEW:The renin-angiotensin system (RAS) plays an important role in modulating cardiovascular function and fluid homeostasis. While the systemic actions of the RAS are widely accepted, the role of the RAS in the brain, its regulation of cardiovascular function, and sympathetic outflow remain controversial. ...

    journal_title:Current hypertension reports

    pub_type: 杂志文章,评审

    doi:10.1007/s11906-018-0810-1

    authors: de Morais SDB,Shanks J,Zucker IH

    更新日期:2018-02-26 00:00:00

  • Using health information technology to improve hypertension management.

    abstract::High-quality medical care requires implementing evidence-based best practices, with continued monitoring to improve performance. Implementation science is beginning to identify approaches to developing, implementing, and evaluating quality improvement strategies across health care systems that lead to good outcomes fo...

    journal_title:Current hypertension reports

    pub_type: 杂志文章,评审

    doi:10.1007/s11906-008-0038-6

    authors: Goldstein MK

    更新日期:2008-06-01 00:00:00

  • Epithelial sodium channel, salt intake, and hypertension.

    abstract::The epithelial sodium channel (ENaC) is a membrane protein made of three different but homologous subunits (a, b, and g) present in the apical membrane of epithelial cells of, for example, the distal nephron. This channel is responsible for salt reabsorption in the kidney and can cause human diseases by increasing cha...

    journal_title:Current hypertension reports

    pub_type: 杂志文章,评审

    doi:10.1007/s11906-003-0005-1

    authors: Hummler E

    更新日期:2003-02-01 00:00:00

  • Diastolic pressure, systolic pressure, or pulse pressure?

    abstract::Diastolic pressure, systolic pressure, and pulse pressure have all been assigned the role of the best predictor of cardiovascular events during the 20th century. At the dawn of the new millennium, concepts that draw attention to vascular mechanics reconcile the seemingly conflicting results of epidemiologic studies, b...

    journal_title:Current hypertension reports

    pub_type: 杂志文章,评审

    doi:10.1007/s11906-000-0010-6

    authors: Vlachopoulos C,O'Rourke M

    更新日期:2000-06-01 00:00:00

  • Hypertension and obstructive sleep apnea.

    abstract::Obstructive sleep apnea is a common disorder that is often unrecognized and underappreciated. Emerging evidence suggests that there is a causal link between obstructive sleep apnea and hypertension. This relationship appears to be independent of other comorbidities that have been previously linked to hypertension, suc...

    journal_title:Current hypertension reports

    pub_type: 杂志文章,评审

    doi:10.1007/s11906-003-0083-0

    authors: Phillips BG,Somers VK

    更新日期:2003-10-01 00:00:00

  • Combination therapy as first-line treatment for hypertension.

    abstract::With the cut-off point between "normal" and "high" blood pressure (BP) being pushed increasingly downward, especially for patients with multiple cardiovascular risk factors, most hypertensives need more than one antihypertensive agent to reach their target BP. In this article, we examine the rationale for combining dr...

    journal_title:Current hypertension reports

    pub_type: 杂志文章,评审

    doi:10.1007/s11906-004-0020-x

    authors: Gavras I,Rosenthal T

    更新日期:2004-08-01 00:00:00

  • Hypertensive renal damage: insights from animal models and clinical relevance.

    abstract::Investigations using chronic blood pressure (BP) radiotelemetry in conscious animals have provided substantial insights into the pathophysiology of hypertensive renal damage. Normal renal autoregulation protects the renal microvasculature from significant injury in most patients with primary hypertension, unless BP ex...

    journal_title:Current hypertension reports

    pub_type: 杂志文章,评审

    doi:10.1007/s11906-004-0091-8

    authors: Griffin KA,Bidani AK

    更新日期:2004-04-01 00:00:00

  • Antihypertensive treatment and new-onset diabetes mellitus.

    abstract::The various antihypertensive regimens have varying effects on glucose metabolism and the development of diabetes mellitus. Recent large hypertension trials have shown great differences in the development of new-onset diabetes among antihypertensive drug therapies. The incidence of diabetes is unchanged or increased by...

    journal_title:Current hypertension reports

    pub_type: 杂志文章,评审

    doi:10.1007/s11906-005-0029-9

    authors: Aksnes TA,Reims HM,Kjeldsen SE,Mancia G

    更新日期:2005-08-01 00:00:00

  • Implementing Home Blood Pressure Monitoring into Clinical Practice.

    abstract:PURPOSE OF REVIEW:To review data supporting the use of home blood pressure monitoring (HBPM) and provide practical guidance to clinicians wishing to incorporate HBPM into their practice. RECENT FINDINGS:HBPM more accurately reflects the risk of cardiovascular events than office blood pressure measurement. In addition,...

    journal_title:Current hypertension reports

    pub_type: 杂志文章,评审

    doi:10.1007/s11906-019-0916-0

    authors: Liyanage-Don N,Fung D,Phillips E,Kronish IM

    更新日期:2019-02-12 00:00:00

  • Ongoing trials: what should we expect after ALLHAT?

    abstract::The publication of the Antihypertensive and Lipid-lowering Treatment to Prevent Heart Attack Trial (ALLHAT) results, when used in conjunction with a new meta-analysis, provides hypertension research with a watershed. Data demonstrate clearly that lowering blood pressure is the most important aspect of hypertension man...

    journal_title:Current hypertension reports

    pub_type: 杂志文章,meta分析

    doi:10.1007/s11906-003-0044-7

    authors: Wang JG,Staessen JA,Heagerty AM

    更新日期:2003-08-01 00:00:00

  • Real-World Strategies to Treat Hypertension Associated with Pediatric Obesity.

    abstract:PURPOSE OF REVIEW:To review the most recent literature on current strategies for the treatment of hypertension associated with pediatric obesity. RECENT FINDINGS:Over the last three decades, childhood and adolescent overweight and obesity prevalence in the USA has continued to rise. Unsurprisingly but rather disturbin...

    journal_title:Current hypertension reports

    pub_type: 杂志文章,评审

    doi:10.1007/s11906-019-0922-2

    authors: Binka E,Brady TM

    更新日期:2019-02-12 00:00:00

  • Antiplatelet treatment in essential hypertension: where do we stand?

    abstract::Antiplatelet agents represent a cornerstone in the management of patients at increased cardiovascular risk. Essential hypertension is considered a major public health problem leading to increased cardiovascular morbidity and mortality. The majority of patients with essential hypertension exhibit also additional cardio...

    journal_title:Current hypertension reports

    pub_type: 杂志文章,评审

    doi:10.1007/s11906-015-0536-2

    authors: Gkaliagkousi E,Gavriilaki E,Douma S

    更新日期:2015-04-01 00:00:00

  • The role of aldosterone in the metabolic syndrome.

    abstract::The metabolic syndrome associates metabolic abnormalities such as insulin resistance and dyslipidemia with increased waist circumference and hypertension. It is a major public health concern, as its prevalence could soon reach 30% to 50% in developed countries. Aldosterone, a mineralocorticoid hormone classically invo...

    journal_title:Current hypertension reports

    pub_type: 杂志文章,评审

    doi:10.1007/s11906-011-0182-2

    authors: Briet M,Schiffrin EL

    更新日期:2011-04-01 00:00:00

  • Activation of mineralocorticoid receptor in salt-sensitive hypertension.

    abstract::The impaired capacity of the kidney to excrete sodium plays an essential role in the development of hypertension. Adrenal corticosteroids control renal handling of sodium by regulating tubular sodium reabsorption in the distal nephron where both mineralocorticoid receptors (MR) and glucocorticoid receptors are express...

    journal_title:Current hypertension reports

    pub_type: 杂志文章,评审

    doi:10.1007/s11906-015-0552-2

    authors: Ayuzawa N,Fujita T

    更新日期:2015-06-01 00:00:00

  • Renin receptor blockade: a better strategy for renal protection than renin-angiotensin system inhibition?

    abstract::Prorenin and renin bind to a 350-amino acid protein called the (pro)renin receptor, which is present on the surface and functions intracellularly. When the receptor's N terminus binds either prorenin or renin, intracellular signaling occurs via extracellular-regulated kinases, which can result in plasminogen activator...

    journal_title:Current hypertension reports

    pub_type: 杂志文章,评审

    doi:10.1007/s11906-008-0075-1

    authors: Müller DN,Luft FC

    更新日期:2008-10-01 00:00:00

  • Organ selective regulation of sympathetic outflow by the brain Angiotensin system.

    abstract::Angiotensin II (Ang II) has actions on the sympathetic nervous system both as a circulating hormone acting on the circumventricular organs and also as a neurotransmitter/ neuromodulator acting within the brain. Administration of Ang II into the cerebral ventricles has diverse effects on sympathetic nerve activity (SNA...

    journal_title:Current hypertension reports

    pub_type: 杂志文章,评审

    doi:10.1007/s11906-013-0355-2

    authors: Ramchandra R,Yao ST,May CN

    更新日期:2013-08-01 00:00:00

  • Compliance and persistence with newer antihypertensive agents.

    abstract::Individuals with hypertension need to stay on therapy with antihypertensive medication to obtain the full benefits of blood pressure reduction. There are important differences in tolerability across antihypertensive drug classes, and these differences influence the extent to which patients are willing to continue taki...

    journal_title:Current hypertension reports

    pub_type: 杂志文章,评审

    doi:10.1007/s11906-002-0021-6

    authors: Gerth WC

    更新日期:2002-12-01 00:00:00

  • Brainstem mechanisms of hypertension: role of the rostral ventrolateral medulla.

    abstract::The central nervous system plays a key role in the regulation of cardiovascular function, and alterations in the central neural mechanisms that control blood pressure may underlie the vast majority of cases of primary hypertension. The well-studied baroreceptor reflex powerfully regulates arterial pressure, though its...

    journal_title:Current hypertension reports

    pub_type: 杂志文章,评审

    doi:10.1007/s11906-003-0030-0

    authors: Sved AF,Ito S,Sved JC

    更新日期:2003-06-01 00:00:00

  • Impaired cardiac function in leptin-deficient mice.

    abstract::The obesity gene product leptin plays an important role in the physiologic regulation of appetite and energy balance. Plasma leptin levels correlate closely with body fat storage and may respond to changes in energy expenditure. Recent evidence has implicated a direct cardiac regulatory action of leptin in addition to...

    journal_title:Current hypertension reports

    pub_type: 杂志文章,评审

    doi:10.1007/s11906-008-0084-0

    authors: Ren J,Ma H

    更新日期:2008-12-01 00:00:00

  • Prehypertension: a possible target for antihypertensive medication.

    abstract::Vascular changes associated with elevated blood pressure may precede the clinical diagnosis of hypertension. Even after the diagnosis is made, associated coronary heart disease and renal disease continue to progress, despite adequate blood pressure control. Early treatment of blood pressure may reduce the incidence of...

    journal_title:Current hypertension reports

    pub_type: 临床试验,杂志文章,评审

    doi:10.1007/s11906-000-0038-7

    authors: Nesbitt SD,Julius S

    更新日期:2000-08-01 00:00:00

  • Effects of relaxin on arterial dilation, remodeling, and mechanical properties.

    abstract::Administering relaxin to conscious rats and humans elicits systemic and renal vasodilation. The molecular mechanisms vary according to the duration of relaxin exposure-so-called "rapid" (within minutes) or "sustained" (hours to days) vasodilatory responses-both being endothelium-dependent. Rapid responses are mediated...

    journal_title:Current hypertension reports

    pub_type: 杂志文章,评审

    doi:10.1007/s11906-011-0231-x

    authors: Conrad KP,Shroff SG

    更新日期:2011-12-01 00:00:00

  • Mineralocorticoid receptor blockade in chronic kidney disease.

    abstract::Aldosterone antagonists have been highly successful in treating congestive heart failure and resistant hypertension. Until recently, therapies targeting the mineralocorticoid receptor in chronic kidney disease (CKD) have received little attention, largely because of the risk of hyperkalemia and the incorrect assumptio...

    journal_title:Current hypertension reports

    pub_type: 杂志文章,评审

    doi:10.1007/s11906-011-0202-2

    authors: Volk MJ,Bomback AS,Klemmer PJ

    更新日期:2011-08-01 00:00:00

  • The sympathetic nervous system in hypertension: back to the future?

    abstract::The seventeenth century London neuroanatomical school headed by Thomas Willis published the first images of the sympathetic nervous system. Nineteenth century European physiologists characterised these as the "pressor nerves". Von Euler's demonstration that the sympathetic transmitter was norepinephrine brought the fi...

    journal_title:Current hypertension reports

    pub_type: 杂志文章,评审

    doi:10.1007/s11906-014-0519-8

    authors: Esler M

    更新日期:2015-02-01 00:00:00

  • Hot Topic: Global Burden of Treating Hypertension-What is the Role of the Emergency Department?

    abstract::Hypertension (HTN) is the most common modifiable risk factor for cardiovascular disease (CVD) morbidity and mortality worldwide. Lower- and middle-income countries (LMICs) are projected to bear the vast majority of this disease burden, but local and regional health care delivery systems in these countries are ill equi...

    journal_title:Current hypertension reports

    pub_type: 杂志文章,评审

    doi:10.1007/s11906-017-0707-4

    authors: Brody AM,Kumar VA,Levy PD

    更新日期:2017-01-01 00:00:00

  • Treatment of diabetic patients with hypertension.

    abstract::This review attempts to highlight the potential of calcium-channel blockers in the prevention of sequelae of diabetes mellitus and hypertension in patients who have both disorders. Evidence-based medicine is driven by the results of randomized, clinical trials. Major contributions were therefore derived from post hoc ...

    journal_title:Current hypertension reports

    pub_type: 杂志文章,评审

    doi:10.1007/s11906-999-0025-6

    authors: Birkenhäger WH,Staessen JA

    更新日期:1999-06-01 00:00:00

  • Renal nerves in the maintenance of hypertension: a potential therapeutic target.

    abstract::Renal sympathetic efferent and afferent nerves, which lie within and immediately adjacent to the wall of the renal arteries, contribute to the maintenance of hypertension. Because the causative factors of hypertension change over time, denervation of both efferent and afferent renal nerves should result in long-term a...

    journal_title:Current hypertension reports

    pub_type: 杂志文章,评审

    doi:10.1007/s11906-010-0108-4

    authors: Katholi RE,Rocha-Singh KJ,Goswami NJ,Sobotka PA

    更新日期:2010-06-01 00:00:00

  • How does preeclampsia predispose to future cardiovascular disease?

    abstract::Over the last few decades, there has been increasing emphasis on cardiovascular disease in women and study of female-specific cardiovascular risk factors. Hypertension in pregnancy, and specifically preeclampsia, has been identified as one such risk factor. In this review, we explore the epidemiological evidence for p...

    journal_title:Current hypertension reports

    pub_type: 杂志文章,评审

    doi:10.1007/s11906-014-0472-6

    authors: Scantlebury DC,Hayes SN

    更新日期:2014-09-01 00:00:00

  • The African American Study of Kidney Disease: do these results indicate that 140/90 mm hg is good enough?

    abstract::Current national guidelines recommend aggressive lowering of blood pressure (< 130/80 mm Hg) in patients with chronic kidney disease (CKD). In this paper, we summarize recent clinical trial data evaluating the effect of lower blood pressure goals on renal outcomes. The epidemiologic data relating blood pressure to pro...

    journal_title:Current hypertension reports

    pub_type: 杂志文章,评审

    doi:10.1007/s11906-005-0072-6

    authors: Rahman M,El-Meanawy A,Romanello J

    更新日期:2005-10-01 00:00:00

  • An Update on Masked Hypertension.

    abstract::Masked hypertension refers to the phenomenon of having a non-elevated clinic blood pressure (BP) despite having an elevated out-of-clinic BP. Masked hypertension is a common phenotype with a cardiovascular risk profile similar to that of sustained hypertension, defined as elevated clinic and out-of-clinic BP. Current ...

    journal_title:Current hypertension reports

    pub_type: 杂志文章,评审

    doi:10.1007/s11906-017-0792-4

    authors: Anstey DE,Pugliese D,Abdalla M,Bello NA,Givens R,Shimbo D

    更新日期:2017-10-25 00:00:00